These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17179103)

  • 1. Hormone replacement therapy and survival after colorectal cancer diagnosis.
    Chan JA; Meyerhardt JA; Chan AT; Giovannucci EL; Colditz GA; Fuchs CS
    J Clin Oncol; 2006 Dec; 24(36):5680-6. PubMed ID: 17179103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II.
    Hildebrand JS; Jacobs EJ; Campbell PT; McCullough ML; Teras LR; Thun MJ; Gapstur SM
    Cancer Epidemiol Biomarkers Prev; 2009 Nov; 18(11):2835-41. PubMed ID: 19843681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of evidence for effect modification by estrogen of association between body mass index and colorectal cancer risk among postmenopausal women.
    Wang Y; Jacobs EJ; Teras LR; Pavluck AL; Rodriguez C; Thun MJ; Calle EE
    Cancer Causes Control; 2007 Oct; 18(8):793-9. PubMed ID: 17619155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical activity and survival after colorectal cancer diagnosis.
    Meyerhardt JA; Giovannucci EL; Holmes MD; Chan AT; Chan JA; Colditz GA; Fuchs CS
    J Clin Oncol; 2006 Aug; 24(22):3527-34. PubMed ID: 16822844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
    Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
    J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort.
    Rodriguez C; Spencer Feigelson H; Deka A; Patel AV; Jacobs EJ; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):655-60. PubMed ID: 18349283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postmenopausal hormone therapy and mortality.
    Grodstein F; Stampfer MJ; Colditz GA; Willett WC; Manson JE; Joffe M; Rosner B; Fuchs C; Hankinson SE; Hunter DJ; Hennekens CH; Speizer FE
    N Engl J Med; 1997 Jun; 336(25):1769-75. PubMed ID: 9187066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Weight gain prior to diagnosis and survival from breast cancer.
    Cleveland RJ; Eng SM; Abrahamson PE; Britton JA; Teitelbaum SL; Neugut AI; Gammon MD
    Cancer Epidemiol Biomarkers Prev; 2007 Sep; 16(9):1803-11. PubMed ID: 17855698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study of leukocyte count as a predictor of incident breast, colorectal, endometrial, and lung cancer and mortality in postmenopausal women.
    Margolis KL; Rodabough RJ; Thomson CA; Lopez AM; McTiernan A;
    Arch Intern Med; 2007 Sep; 167(17):1837-44. PubMed ID: 17893304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer risk factors and second primary malignancies among women with breast cancer.
    Trentham-Dietz A; Newcomb PA; Nichols HB; Hampton JM
    Breast Cancer Res Treat; 2007 Oct; 105(2):195-207. PubMed ID: 17186360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSAID use and survival after breast cancer diagnosis in post-menopausal women.
    Blair CK; Sweeney C; Anderson KE; Folsom AR
    Breast Cancer Res Treat; 2007 Jan; 101(2):191-7. PubMed ID: 16823508
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
    Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
    Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body mass and endometrial cancer risk by hormone replacement therapy and cancer subtype.
    McCullough ML; Patel AV; Patel R; Rodriguez C; Feigelson HS; Bandera EV; Gansler T; Thun MJ; Calle EE
    Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):73-9. PubMed ID: 18187388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
    Svartberg J; von Mühlen D; Kritz-Silverstein D; Barrett-Connor E
    Menopause; 2009; 16(5):888-91. PubMed ID: 19421076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of hormone replacement therapy (HRT) and survival following breast cancer diagnosis.
    Fletcher AS; Erbas B; Kavanagh AM; Hart S; Rodger A; Gertig DM
    Breast; 2005 Jun; 14(3):192-200. PubMed ID: 15927828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women?
    Wolf LA; Terry PD; Potter JD; Bostick RM
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):676-83. PubMed ID: 17416757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy.
    Hoffmeister M; Raum E; Krtschil A; Chang-Claude J; Brenner H
    Clin Pharmacol Ther; 2009 Oct; 86(4):416-24. PubMed ID: 19606090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Menstrual and reproductive history, postmenopausal hormone use, and risk of benign proliferative epithelial disorders of the breast: a cohort study.
    Cui Y; Page DL; Lane DS; Rohan TE
    Breast Cancer Res Treat; 2009 Mar; 114(1):113-20. PubMed ID: 18360772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer screening using fecal occult blood test and subsequent risk of colorectal cancer: a prospective cohort study in Japan.
    Lee KJ; Inoue M; Otani T; Iwasaki M; Sasazuki S; Tsugane S;
    Cancer Detect Prev; 2007; 31(1):3-11. PubMed ID: 17289293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colorectal cancer in middle-aged women in relation to hormonal status: a report from the Women's Health in the Lund Area (WHILA) study.
    Nazeri K; Khatibi A; Nyberg P; Agardh CD; Lidfeldt J; Samsioe G
    Gynecol Endocrinol; 2006 Aug; 22(8):416-22. PubMed ID: 17012102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.